Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001640334-20-002026)

Filing Details

Accession Number:: 0001640334-20-002026
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-11 14:52:32
Reporting Period:: 2020-08-07

Accepted Time:: 2020-08-11 14:52:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516551	Emerald Bioscience Inc.	EMBI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1261140	L James Heppell	5910 Pacific Center Blvd Suite 320 San Diego CA 92121		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-07	500,000	$50,000.00	500,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director Option Grant (Right to Buy)	Acquisiton	2020-08-07	1,000,000	$0.00	1,000,000	$0.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,200,000		2030-08-07	No	4	A	Direct

Footnotes

Private purchase transaction from Emerald Health Sciences at $0.10 per share.
Each of the Options shall be exercisable for a price of $0.045 per Option Share for ten years from August 7, 2020 (the "Grant Date") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over two years.